CRNX vs. MAAS
CRNX (Crinetics Pharmaceuticals, Inc.) and MAAS (Highest Performances Holdings Inc) are both stocks. CRNX operates in Biotechnology (Healthcare), while MAAS operates in Asset Management (Financial Services). Over the past 5 years, CRNX returned 35.96%/yr vs -43.07%/yr for MAAS. Their 0.07 correlation means their historical movements had little consistent relationship.
Performance
CRNX vs. MAAS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRNX achieves a 79.42% return, which is significantly lower than MAAS's 229.44% return.
CRNX
- 1D
- -0.13%
- 1M
- 97.77%
- 6M
- 67.24%
- YTD
- 79.42%
- 1Y
- 200.00%
- 3Y*
- 62.54%
- 5Y*
- 35.96%
- 10Y*
- —
- ALL TIME*
- 20.04%
MAAS
- 1D
- -2.04%
- 1M
- 18.36%
- 6M
- 191.64%
- YTD
- 229.44%
- 1Y
- 387.40%
- 3Y*
- -63.26%
- 5Y*
- -43.07%
- 10Y*
- —
- ALL TIME*
- -34.27%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $259.03M | $689.74M | $264.69M | |
| $1.18M | $2.20M | $1.60M |
CRNX vs. MAAS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
CRNX Crinetics Pharmaceuticals, Inc. | 79.42% | -8.96% | 43.70% | 94.43% | -35.59% | 101.35% | -43.76% | 11.76% |
MAAS Highest Performances Holdings Inc | 229.44% | -73.13% | -94.57% | -19.24% | 14.89% | 7.78% | -1.28% | -3.10% |
Correlation
The correlation between CRNX and MAAS is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (3Y) Balances recent behavior with more history. | 0.07 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.05 |
Correlation (All Time) Calculated using the full available price history since Mar 29, 2019 | 0.07 |
Fundamentals
CRNX:
$8.84B
MAAS:
$5.71B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRNX vs. MAAS — Risk / Return Rank
CRNX
MAAS
CRNX vs. MAAS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Crinetics Pharmaceuticals, Inc. (CRNX) and Highest Performances Holdings Inc (MAAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRNX | MAAS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.99 | ||
| Sortino ratioReturn per unit of downside risk | +1.13 | ||
| Omega ratioGain probability vs. loss probability | 1.58 | 1.47 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 4.58 | 9.29 | -4.71 |
| Martin ratioReturn relative to average drawdown | 9.07 | 31.85 | -22.78 |
Loading charts...
Drawdowns
CRNX vs. MAAS - Drawdown Comparison
The maximum CRNX drawdown since its inception was -68.70%, smaller than the maximum MAAS drawdown of -99.71%. Use the drawdown chart below to compare losses from any high point for CRNX and MAAS.
Loading charts...
Drawdown Indicators
| CRNX | MAAS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.70% | -99.71% | +31.01% |
Max Drawdown (1Y)Largest decline over 1 year | -42.21% | -40.77% | -1.44% |
Max Drawdown (3Y)Largest decline over 3 years | -57.88% | -99.56% | +41.68% |
Max Drawdown (5Y)Largest decline over 5 years | -57.88% | -99.56% | +41.68% |
Current DrawdownCurrent decline from peak | -0.46% | -97.96% | +97.50% |
Average DrawdownAverage peak-to-trough decline | -36.98% | -65.73% | +28.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.27% | 11.89% | +9.38% |
Volatility
CRNX vs. MAAS - Volatility Comparison
Crinetics Pharmaceuticals, Inc. (CRNX) has a higher volatility of 68.84% compared to Highest Performances Holdings Inc (MAAS) at 49.38%. This indicates that CRNX's price experiences larger fluctuations and is considered to be riskier than MAAS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRNX | MAAS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 68.84% | 49.38% | +19.46% |
Volatility (6M)Calculated over the trailing 6-month period | 76.63% | 88.59% | -11.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 113.40% | 102.46% | +10.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.55% | 162.84% | -85.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 74.07% | 140.42% | -66.35% |
Dividends
CRNX vs. MAAS - Dividend Comparison
Neither CRNX nor MAAS has paid dividends to shareholders.
Financials
CRNX vs. MAAS - Financials Comparison
This section allows you to compare key financial metrics between Crinetics Pharmaceuticals, Inc. and Highest Performances Holdings Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRNX and MAAS have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRNX has higher volatility (68.84%) compared to MAAS (49.38%). In terms of maximum drawdown, CRNX dropped -68.70% vs MAAS's -99.71%.
MAAS currently has the higher Sharpe Ratio (3.70 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRNX and MAAS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer